-
DiscoveryProbe Natural Product Library Plus: Assay Logic
2026-08-10
DiscoveryProbe Natural Product Library Plus supports a decision-driven strategy for natural product screening, combining chemical diversity with automation-ready assay design. This article shows how metabolic target evidence from Cryptosporidium research can guide biochemical, phenotypic, and high-content follow-up without overstating validation.
-
Ruxolitinib Phosphate: From JAK to Mitochondria
2026-08-09
Ruxolitinib phosphate (INCB018424) is more than a conventional JAK1/JAK2 research tool. Recent evidence in anaplastic thyroid carcinoma connects JAK/STAT signaling pathway modulation to DRP1-dependent mitochondrial dynamics, apoptosis, and GSDME-mediated pyroptosis. This thought-leadership guide translates those findings into practical strategies for disease modeling, assay design, compound positioning, and translational decision-making.
-
ST3GAL1 Sialylation Drives F. nucleatum Adhesion
2026-08-08
The reference study identifies ST3GAL1-dependent sialylation as a host-cell determinant of Fusobacterium nucleatum adhesion to colorectal cancer cells. Its findings connect altered surface glycans with sustained bacterial colonization and an H3K27ac/ANGPTL4 cancer-promoting axis, providing a mechanistic framework for studying intratumoral microbial persistence.
-
CUX2 Neuron Loss and DNA Damage in Neuroinflammation
2026-08-07
The reference study identifies accumulated DNA damage and insufficient repair as a major contributor to the selective loss of CUX2-positive layer 2/3 excitatory neurons during multiple sclerosis-associated neuroinflammation. By integrating human MS tissue, inflammatory mouse models, neuronal perturbation experiments, and interferon-γ exposure, it connects inflammatory oxidative stress with cell-type-specific neuronal vulnerability.
-
TP53-Dependent DHODH Inhibition in NPC: Mechanisms and Impli
2026-08-07
Dong et al. provide the first comprehensive evidence that targeting dihydroorotate dehydrogenase (DHODH) in nasopharyngeal carcinoma (NPC) yields potent antitumor effects primarily through a TP53-dependent mechanism. This work establishes nucleic acid metabolism as a crucial driver of NPC progression and highlights the therapeutic promise of DHODH inhibition in tumors with functional TP53.
-
Eliminating Chemotherapy-Induced Senescent Cells in TP53 Wil
2026-08-06
This study demonstrates that BH3 mimetics can selectively eliminate chemotherapy-induced senescent cells in TP53 wild-type breast cancer, a setting where standard therapies often fail to induce tumor cell death. By targeting antiapoptotic BCL-2 family proteins, the research provides a mechanistic foundation for combining senolytic agents with chemotherapy to improve outcomes in poor-prognosis breast cancers.
-
MDL 28170: Calpain Inhibition for Translational Neuroprotect
2026-08-06
Discover how MDL 28170, a selective calpain inhibitor, advances neuroprotection and experimental design in translational neuroscience. This article explores mechanistic depth, protocol nuances, and cross-domain implications beyond standard assay workflows.
-
Baicalein (5,6,7-trihydroxy-2-phenylchromen-4-one): Advancin
2026-08-05
Explore how Baicalein, a potent 5,6,7-trihydroxy-2-phenylchromen-4-one flavonoid, enables precision modulation of cancer and inflammation pathways. This in-depth guide uniquely bridges mechanistic insight with advanced assay design, offering practical solutions beyond standard protocols.
-
Cy3 Rabbit Anti-Goat IgG (H+L) Antibody: Practical Use Guide
2026-08-05
The Cy3 Rabbit Anti-Goat IgG (H+L) Antibody enables sensitive detection of goat IgG primaries in fluorescence-based immunodetection workflows, such as ICC/IF, IHC, flow cytometry, and ELISA. It is not suitable for non-goat primary antibodies or use outside validated immunoassay protocols. Proper handling and workflow alignment are essential for reliable results and minimized background.
-
Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO): Techn
2026-08-04
The Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO) is designed to prevent protein degradation during extraction and processing, particularly in workflows requiring preservation of phosphorylation or cation-sensitive enzymatic activities. It should not be used when metalloprotease inhibition via EDTA is required or where DMSO intolerance is a concern.
-
Leupeptin Hemisulfate Salt: Precision Tools for Protein Degr
2026-08-04
Leupeptin hemisulfate salt is a gold-standard reversible inhibitor that precisely regulates serine and cysteine protease activity across workflows in protein degradation and viral replication research. This article translates advanced protocols, troubleshooting, and the latest epigenetic insights into actionable guidance for bench scientists.
-
Trichostatin A (TSA): Epigenetic Modulation and Cancer Resea
2026-08-03
Trichostatin A (TSA) is a potent, reversible HDAC inhibitor used in epigenetic and cancer research. TSA induces histone hyperacetylation, cell cycle arrest, and differentiation, with pronounced antiproliferative effects in breast cancer models. Its robust performance in hypoxic immune environments and its well-defined protocol parameters make TSA a standard tool for dissecting chromatin regulation and oncogenic processes.
-
Cy3 TSA Fluorescence System Kit: Signal Amplification in IHC
2026-08-03
Unlock unmatched sensitivity in immunohistochemistry and in situ hybridization with the Cy3 TSA Fluorescence System Kit. This workflow-centric guide reveals core protocol optimizations, advanced applications for rare biomolecule detection, and troubleshooting strategies, all anchored in the latest epigenetic research.
-
Bazedoxifene: Precision in Estrogen Receptor Modulation Rese
2026-08-02
Explore the advanced pharmacological profile and research applications of Bazedoxifene, a third-generation selective estrogen receptor modulator. This in-depth article highlights its unique mechanistic properties and experimental advantages for osteoporosis treatment research.
-
E-64 L-trans-epoxysuccinyl Peptide: Applied Cysteine Proteas
2026-08-01
E-64, a potent L-trans-epoxysuccinyl peptide, delivers robust and selective cysteine protease inhibition across diverse biochemical and cell-based assays. This guide distills experimental workflows, troubleshooting strategies, and key innovations—empowering researchers to harness E-64’s full potential in mechanistic and translational studies.